Universal Health Services Earnings Calls
| Release date | Apr 27, 2026 |
| EPS estimate | $5.29 |
| EPS actual | $5.62 |
| EPS Surprise | 6.24% |
| Revenue estimate | 4.388B |
| Revenue actual | 4.495B |
| Revenue Surprise | 2.45% |
| Release date | Feb 25, 2026 |
| EPS estimate | $5.92 |
| EPS actual | $5.88 |
| EPS Surprise | -0.676% |
| Revenue estimate | 4.505B |
| Revenue actual | 4.486B |
| Revenue Surprise | -0.412% |
| Release date | Oct 27, 2025 |
| EPS estimate | $4.66 |
| EPS actual | $5.69 |
| EPS Surprise | 22.10% |
| Revenue estimate | 4.505B |
| Revenue actual | 4.495B |
| Revenue Surprise | -0.205% |
| Release date | Jul 28, 2025 |
| EPS estimate | $4.92 |
| EPS actual | $5.35 |
| EPS Surprise | 8.74% |
| Revenue estimate | 4.238B |
| Revenue actual | 4.284B |
| Revenue Surprise | 1.09% |
Last 4 Quarters for Universal Health Services
Below you can see how UHS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 28, 2025 |
| Price on release | $154.95 |
| EPS estimate | $4.92 |
| EPS actual | $5.35 |
| EPS surprise | 8.74% |
| Date | Price |
|---|---|
| Jul 22, 2025 | $162.68 |
| Jul 23, 2025 | $164.82 |
| Jul 24, 2025 | $155.46 |
| Jul 25, 2025 | $155.60 |
| Jul 28, 2025 | $154.95 |
| Jul 29, 2025 | $162.82 |
| Jul 30, 2025 | $165.44 |
| Jul 31, 2025 | $166.45 |
| Aug 01, 2025 | $162.98 |
| 4 days before | -4.75% |
| 4 days after | 5.18% |
| On release day | 5.08% |
| Change in period | 0.184% |
| Release date | Oct 27, 2025 |
| Price on release | $214.03 |
| EPS estimate | $4.66 |
| EPS actual | $5.69 |
| EPS surprise | 22.10% |
| Date | Price |
|---|---|
| Oct 21, 2025 | $206.80 |
| Oct 22, 2025 | $210.40 |
| Oct 23, 2025 | $208.63 |
| Oct 24, 2025 | $210.68 |
| Oct 27, 2025 | $214.03 |
| Oct 28, 2025 | $219.32 |
| Oct 29, 2025 | $225.30 |
| Oct 30, 2025 | $218.69 |
| Oct 31, 2025 | $217.01 |
| 4 days before | 3.50% |
| 4 days after | 1.39% |
| On release day | 2.47% |
| Change in period | 4.94% |
| Release date | Feb 25, 2026 |
| Price on release | $230.73 |
| EPS estimate | $5.92 |
| EPS actual | $5.88 |
| EPS surprise | -0.676% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $230.00 |
| Feb 20, 2026 | $230.49 |
| Feb 23, 2026 | $232.60 |
| Feb 24, 2026 | $229.98 |
| Feb 25, 2026 | $230.73 |
| Feb 26, 2026 | $204.33 |
| Feb 27, 2026 | $206.10 |
| Mar 02, 2026 | $206.42 |
| Mar 03, 2026 | $204.85 |
| 4 days before | 0.317% |
| 4 days after | -11.22% |
| On release day | -11.44% |
| Change in period | -10.93% |
| Release date | Apr 27, 2026 |
| Price on release | $179.51 |
| EPS estimate | $5.29 |
| EPS actual | $5.62 |
| EPS surprise | 6.24% |
| Date | Price |
|---|---|
| Apr 21, 2026 | $178.55 |
| Apr 22, 2026 | $180.72 |
| Apr 23, 2026 | $181.18 |
| Apr 24, 2026 | $174.35 |
| Apr 27, 2026 | $179.51 |
| Apr 28, 2026 | $162.54 |
| Apr 29, 2026 | $167.97 |
| Apr 30, 2026 | $168.27 |
| May 01, 2026 | $167.00 |
| 4 days before | 0.538% |
| 4 days after | -6.97% |
| On release day | -9.45% |
| Change in period | -6.47% |
Universal Health Services Earnings Call Transcript Summary of Q1 2026
Key points for investors: Universal Health Services (UHS) reported a solid Q1 2026 performance with revenue growth of 9.6%, adjusted EBITDA (net of NCI) up 8.4%, and adjusted EPS up 16.1% versus Q1 2025. Management announced the acquisition of Talkspace (virtual outpatient behavioral health platform), positioning it to accelerate UHS’s outpatient behavioral strategy and create an end-to-end behavioral continuum; management expects the deal to be accretive within the first 12 months and to reach an effective EBITDA multiple in the single digits by year three. Q1 volumes were impacted by weaker flu season and winter weather (acute admissions down; ED visits +2%), while same-facility acute revenue rose 8.2% (6.2% ex-health plan benefit) and same-facility acute revenue per adjusted admission rose 6.3% (4.9% ex-prior-period supplemental benefit). Behavioral same-facility net revenues rose 7.3% and behavioral same-facility EBITDA rose 8.4% (core behavioral growth ~4.3% excluding prior-period supplemental items). Key headwinds: an estimated $75 million FY pretax impact from health insurance exchange (HIX) premium attrition and related bad-debt/uncompensated-care pressure; modest near-term drag from de novo hospital openings (new Florida hospital expected to be loss-making its first year). Management reiterated 2026 guidance and plans to reevaluate with Q2 results. Capital allocation: Q1 buybacks of $127 million (675k shares) with $1.3 billion of repurchase authorization remaining; continued buybacks targeted with previously stated annual minimum buyback target (~$800–$900 million); late-April expansion of credit facility capacity by $900 million to support Talkspace closing and flexibility for M&A and buybacks. Operational/strategic priorities: continue outpatient expansion (Thousand Branches and Talkspace integration), invest in AI (eight revenue-cycle AI use cases live; more clinical AI pilots planned with Hippocratic AI), moderate behavioral wage growth (~6% expected in 2026 vs 7–8% in 2025), and continued focus on revenue-cycle technology and denials management. Overall tone: constructive—management believes the company can deliver margin and earnings expansion over the year despite near-term seasonal and HIX headwinds, with strategic upside from Talkspace and ongoing operational efficiency initiatives.
Sign In
Buy UHS